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Research Article
Enhanced itch elicited by capsaicin
in a chronic itch model
Guang Yu, PhD1,2, Niuniu Yang, MD1, Fengxian Li, MD2,3,
Meijuan Chen, PhD1, Changxiong J Guo, BS2, Changming Wang,
PhD1, Danyou Hu, BS1, Yan Yang, BS1, Chan Zhu, BS1,
Zhongli Wang, PhD1, Hao Shi, MD1, Tana Gegen, MD1, Ming Tang,
MS1, Qian He, MS1, Qin Liu, PhD2 and Zongxiang Tang, PhD1
Abstract
Chronic itch (pruritus) is an important clinical problem. However, the underlying molecular basis has yet to be understood.
The Transient Receptor Potential Vanilloid 1 channel is a heat-sensitive cation channel expressed in primary sensory neurons
and involved in both thermosensation and pain, but its role in chronic itch remains elusive. Here, we for the first time
revealed an increased innervation density of Transient Receptor Potential Vanilloid 1-expressing sensory fibers in the skin
afflicted with chronic itch. Further analysis indicated that this phenomenon is due to an expansion of Transient Receptor
Potential Vanilloid 1-expressing sensory neurons under chronic itch conditions. As a functional correlates of this neuronal
expansion, we observed an enhanced neuronal responsiveness to capsaicin under the dry skin conditions. Importantly, the
neuronal hypersensitivity to capsaicin results in itch, rather than pain sensation, suggesting that the up-regulated Transient
Receptor Potential Vanilloid 1 underlies the pain-to-itch switch under chronic itchy conditions. The study shows that there
are different mechanisms of chronic pain and itching, and Transient Receptor Potential Vanilloid 1 plays an important role in
chronic itch.
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Introduction
Pain and itch aﬀect billions of people worldwide and
cause deleterious eﬀects on both quality of life and
productivity. Although both are unpleasant sensations
involving sensory discriminative, cognitive, evaluative,
aﬀective, and motivational components, they elicit distinct
behaviors and have an antagonistic interaction – pain can
inhibit itch.1,2 Recent progress suggests that itch and pain
are encoded and transmitted by discrete groups of pri-
mary sensory neurons (pruriceptive neurons and nocicep-
tive neurons, respectively) in the trigeminal ganglia (TG)
and dorsal root ganglia (DRG).1,2
The boundary between pain and itch, however, is
blurred under pathological conditions. For instance,
iontophoresis of histamine-inducing itch is perceived as
painful in chronic pain patients,3,4 while patients with
chronic itch perceive noxious mechanical, thermal, and
chemical stimuli as itchy.5–7 However, the underlying
molecular mechanisms remain unclear.
Transient Receptor Potential Vanilloid 1 (TRPV1) is a
heat-sensitive cation channel that is selectively expressed
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in a population of primary sensory neurons in the TG and
DRG. TRPV1 plays an important role in thermal and
pain sensations. Furthermore, studies indicate that
TRPV1 serves as the downstream transduction channel
of histamine H1 receptors and is required for histamine-
induced itch.8,9 However, whether TRPV1 is involved in
histamine-independent chronic itch and whether it medi-
ates pain-to-itch switch under chronic itch remain unclear.
Here, we showed an up-regulation of TRPV1 in dry skin-
associated chronic itch, which lead to an enhanced neur-
onal responsiveness to capsaicin. Interestingly, TRPV1
neuronal hypersensitivity plays an important role in the
pain-to-itch switch under chronic itchy conditions, which
shed new light on the sensory coding in chronic itch.
Materials and methods
Animals
All experiments were performed in accordance with
protocols approved by the Animal Care and Use
Committee at the Nanjing University of Chinese
Medicine. All mice used in the behavioral tests were 8-
to10-week-old males backcrossed to C57Bl/6 back-
ground for at least six generations. Pirt-GCaMP3 mice
were generated by Dr. Xinzhong Dong. GCaMP3 and
neomycin resistance genes were inserted into the Pirt
locus using targeted homologous recombination. The
inserted genes were knocked-in in frame with the Pirt
promoter and replaced the entire coding region of the
Pirt gene.10 Pirt-GCaMP3 heterozygotes were used in
all Ca2þ imaging experiments.
TRPV1-PLAP transgenic mice were purchased from
Jackson Laboratories. PLAP-pGK-Hyg-loxP cassette
was knocked in and replaces the entire open reading
frame of TRPV1.
Animal model
To experimentally induce dry skin, we treated the cheek or
the nape of mice with acetone-ether-water (AEW) as pre-
viously reported.11 Animal were shaved at the cheek three
days before the start of treatment. A mixture of acetone
and diethylether (1:1) was applied to the shaved area for
20 s, followed immediately by distilled water for 30 s.
Acetone and ether remove lipid components in the stra-
tum corneum and disrupts the cutaneous barrier.
Subsequent water treatment exerts hypotonic stress on
the keratinocytes. The animals were treated twice daily.
Behavioral test
Animals were housed in and behavior experiments were
performed in a controlled environment of 20C–24C,
45%–65% humidity, and with a 12-h day/night cycle.
Animals were acclimated to the testing environment for
10min before the initiation of behavior tests. Animal
behavior was analyzed by investigators who were blind
to genotype and animal treatment conditions.
Scratching behavior in AEW model animals was
observed for 1 h (8:30 a.m. to 9:30 a.m.) before AEW
treatments. Scratching and wiping behavior induced by
subcutaneously injected capsaicin were observed for
30min. A bout of scratching was deﬁned as a continuous
scratching movement with a hindpaw directed at the
treated site or drug injection site. A bout of wiping was
deﬁned as a continuous wiping movement with a fore-
paw directed at the area of the treatment site.
TRPV1-PLAP histochemistry
TRPV1-PLAP heterozygous mice were anesthetized
with 1% sodium pentobarbital (50mg/kg, i.p.), and trans-
cardially perfused with 10–15mL of 0.1 M phosphate-buf-
fered saline (0.1M PBS, pH 7.4, 4C) followed by 20–25mL
ice-cold 4% paraformaldehyde (pH 7.4). TGs were isolated
from perfused mice, post-ﬁxed in 4% paraformaldehyde
(PFA) in PBS for 30min, and cryoprotected in 30% sucrose
at 4C for 24h. TGs were then embedded in optimum cut-
ting temperature compound (OCT, Leica, Wetalar,
Germany) and rapidly frozen at 20C (CM1950, Leica).
Cryoembedded tissues were cut into 20mm thick slices using
sliding microtome (CM1950, Leica).
TRPV1-PLAP staining was performed as previously
described.12 Brieﬂy, the skin of TRPV1-PLAP transgenic
mouse was dissected after CO2 euthanasia and post-ﬁxed
with 1% PFA overnight. For heat inactivation (65C),
skin and TG sections were performed for 2h. PLAP signal
was detected by 5-bromo-4-chloro-3-indolyl phosphate
(BCIP)/nitroblue tetrazolium (NBT) in alkaline phosphatase
(AP) buﬀer (0.1MNaCl, 50mMMgCl2, 0.1MTris pH 9.5)
on shaker at room temperature overnight.
Tissues were washed with Hank’s Balanced Salt
Solution (HBSS) after the signal appeared. All imaging
was performed with an Olympus ﬂuorescence micro-
scope (BX51, Olympus, Japan).
Real-time PCR
Total RNA from freshly dissected TGs were isolated and
puriﬁed using a TRIzol/chloroform (Life Technologies,
Carlsbad, CA, USA) and isopropanol precipitation pro-
cedure, in accordance with the manufacture’s protocol.
cDNA was compiled using the Transcript First Strand
cDNA Synthesis Kit (Roche, Basel, Switzerland). Real-
time PCR was performed using Light Cycler 480 SYBR
Green I Master Mix (Roche, Basel, Switzerland) and a
Light Cycler 480 II Real-Time PCR instrument (Roche,
Basel, Switzerland), according to the manufacturer’s
recommended protocol. In short, 1 mL of cDNA
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was used for each 20l reaction. Primers (forward
primer: ATCATCAACGAGGACCCAGG, reverse
primer: TGCTATGCCTATCTCGAGTGC) were used
to amplify TRPV1 of the mouse. Calibrations and nor-
malizations were done using the 2CT method, where
CT¼ (CT (target gene)CT (reference gene)) (CT
(calibrator)CT (reference gene)). Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as the ref-
erence gene for real-time PCR experiments.
Western blot
Total protein from freshly dissected TGs were isolated and
puriﬁed using a TRIzol/chloroform (Life Technologies)
and isopropanol precipitation procedure after RNA extrac-
tion, in accordance with the manufacture’s protocol. The
extracted proteins were preserved at 20C. The protein
concentration of the supernatant was determined by
Bicinchoninic Acid (BCA) assay. b-actin was selected as
an internal control. Polyclonal antibody to the TRPV1
(Neuromics, USA) was used at 1/500 dilution and a mono-
clonal antibody to the b-actin protein (Santa Cruz
Biotechnology, Dallas, TX) was used at a 1/-1000 dilution.
Equal quantities of protein (60mg per lane) were resolved
on 12% SDS-polyacrylamide gels. Western blotting was
preformed as detailed previously. The intensity of the
signal was used to estimate the relative expression of the
TRPV1 protein in the tissue extracts.
TG neuron culture
TGs were dissected from 6–8 week old mice and collected
in ice cold DH10 medium (90% DMEM/F-12, 10% FBS,
100U/ml penicillin, 100mg/ml streptomycin, Gibco).
Dissected TGs were then digested for 40min at 37C in a
protease solution (5mg/ml dispase, 1mg/ml collagenase
type I in HBSS without Ca2þorMg2þ, Gibco). After diges-
tion, TGs were triturated to free neurons and pelleted by
centrifugation (1000 r/min, 3min). Pelleted neurons were
then resuspended in DH10 medium and applied onto 15%
Bovine Serum Albumin (BSA) column. Neurons were
enriched in the bottom of the column after centrifugation
(2000 r/min, 3min). Pelleted neurons were then resuspened
in DH10 medium and supplemented with nerve growth
factor (NGF) (20ng/ml) and glial cell line-derived neuro-
trophic factor (GDNF) (25ng/ml). Cells were plated onto
glass coverslips coated with poly-D-lysine (0.5mg/ml,
Sigma) and laminin (10mg/ml, Sigma).
Ca2þ imaging
Cultured TG neurons and whole TGs from AEW-treated
mice were adopted for Ca2þ imaging. For cultured neu-
rons, dissociated neurons were incubated for 18–24 h
(95% O2, 5% CO2) before testing.
13 For whole TGs
imaging, mice were sacriﬁced by CO2 asphyxiation, and
TG explants were isolated and allowed to recover for
30min in Ca2þ imaging buﬀer before testing. All experi-
ments were performed at room temperature (25C) inside
a bath perfusion chamber. Green ﬂuorescent protein
(GFP) signals from Pirt-GCaMP3 mice were imaged at
488 nm excitation to detect Ca2þ transients.
Data analysis
All data are presented as mean SEM. Statistical com-
parisons were performed using two-tailed Student’s t
tests. Diﬀerences were considered statistically signiﬁcant
at p< 0.05.
Results
Adoption of a dry-skin itchy model in mice
To explore the molecular mechanisms of chronic itch, we
utilized a well-established dry skin itch model generated
by topical application of an acetone/ether mixture fol-
lowed by water (AEW, Figure 1(a)).11,14–18 AEW treat-
ment produces severe skin barrier dysfunction, robust
scratching, and changes in gene expression in sensory
neurons and the skin,11,15,17 which recapitulates the dry
skin symptom present in many chronic itchy conditions
in humans, including xerodermia, atopic dermatitis, and
psoriasis. During AEW treatment in mice, itch behavior
follows a clear temporal pattern that includes induction,
maintenance, and recovery (Figure 1(b)). Itch-related
scratching behaviors increase during the induction
phase, plateau during the maintenance phase, and dimin-
ish during the recovery phase. However, it remains
unclear how the AEW treatment leads to chronic itch.
Our pilot studies indicate that mast cell deﬁciency does
not prevent AEW-induced itch in Kit(w-sh) (SASH)
mice (Figure 1(c)), arguing against the involvement of
mast cells or allergic reactions in dry skin itch. In
addition, dexamethasone, a steroid drug with potent
anti-inﬂammatory and immunosuppressant eﬀects,
cannot relieve AEW itch (data not shown), despite its
wide use in treating chronic skin diseases including psor-
iasis and atopic dermatitis. These results, together with
previous studies,11 strongly suggest that the pathogenesis
of AEW itch is independent of allergic immune reactions
and provide a unique model for us to study the mechan-
isms of dry skin-associated chronic itch.
Increased TRPV1 expression in the dry skin model
Histological examinations reveal increased cutaneous
nerve densities in the patients with atopic dermatitis,
which is positively correlated with itch severity. This
observation suggests that higher density of sensory
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ﬁbers may be at least partly responsible for intense itch-
ing in the skin. To determine the role of TRPV1 expres-
sion in chronic itch induced by AEW, we ﬁrst examined
the changes in their axon innervation in the skin area
treated with AEW. Indeed, the innervation density of
TRPV1þ sensory ﬁbers ^is signiﬁcantly increased under
dry skin conditions (Figure 2(a)–(c)). To quantify the
changes in the innervation density of TRPV1þ sensory
ﬁbers, we measured the length of TRPV1þ sensory ﬁbers
per square millimeter. The density of TRPV1þ sensory
ﬁber was increased by 35.89% in AEW-treated mice
(2.87 0.25 (control) vs. 3.90 0.20 (AEW fourth day);
Figure 2(d)), implying a potential involvement of
TRPV1þ sensory ﬁbers in chronic itch.
To determine whether the increased innervation dens-
ity of TRPV1þ sensory ﬁbers is due to an expansion of
TRPV1þ sensory neurons under the dry skin condition,
we examined the changes in the proportion of TRPV1þ
neurons in the TGs after AEW treatments. Using
TRPV1-PLAP reporter mice, we examined the TRPV1
expression by conducting PLAP-histachemistry. The tri-
geminal nerve comprises three branches: the ophthalmic
(V1), maxillary (V2), and mandibular (V3), which
innervate discrete orofacial regions, respectively
(Figure 1(a)). We generated AEW cheek model select-
ively on the cheek skin innervated by the V3 branch of
the trigeminal nerve (Figure 1(a)) and found that the
proportion of TRPV1þ neurons signiﬁcantly increased
in V3 (20.2 1.77 (control) vs. 30.2 1.84 (AEW
fourth day) vs. 32.9 1.75 (AEW eighth day); Figure
3(e)–(h)), but not in the neighboring V2 branch
(18.5 0.99 (control) vs. 18.8 2.38 (AEW fourth day)
vs. 20.3 0.91 (AEW eighth day); Figure 3(a)–(d)).
Correlating well with this result, real-time PCR and
Western blot results conﬁrm that the expression of
TRPV1 in the TG was signiﬁcant increased after AEW
treatment (Figure 4). Together, these data indicate that
dry skin causes an expansion of TRPV1þ neurons in the
TGs and hence increased TRPV1þ axonal innervation in
the skin.
Enhanced neuronal responsiveness to capsaicin
under the dry skin conditions
In addition to molecular characterization, we further
studied the changes in physiological properties of
TRPV1þ neurons under the dry skin condition using
two complementary strategies. First, we cultured
Figure 1. AEW mice shows significant increase in scratching behavior. (a) Diagram of the AEW treatment location and trigeminal nerve
dermatome. (b) Spontaneous scratching behavior in AEW treated wild-type mice. Compared with water-treated mice (n¼ 6), AEW
treatment (from D0 to D7) induces significant scratching behavior, starting from the third day and increases dramatically until the peak on
the seventh day (n¼ 6). The arrows in the figure indicate the treatment of AEW. (c) Mast cell deficiency does not prevent AEW itch in
Kit(w-sh) mice.
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TG neurons from AEW-treated mice at the fourth day
and examined their responses to capsaicin using calcium
imaging techniques. The responsiveness to 50 nM capsa-
icin was signiﬁcantly increased in TG neurons
from AEW-treated lateral (37.41% 4.29%), compared
with those from the contralateral (18.97% 2.26%,
p< 0.01; Figure 5). Furthermore, capsaicin of higher
concentration (500 nM) causes more responses in sensory
neurons in both groups, but sensory neurons from
AEW-treated lateral display more responsiveness
(61.85% 3.61%) than controls from contralateral
ganglia (41.30% 2.25%, p< 0.01; Figure 5). The
advantage of this strategy is that cultured sensory neu-
rons are highly sensitive to chemical stimuli and easy to
Figure 2. AEW treatment increases TRPV1þ sensory fibers density in cheek skin. (a) PLAP staining of TRPV1þ sensory fibers that
innervate the cheek skin in cheek. (b) TRPV1þ sensory fibers density is increased in cheek skin at the fourth day of AEW treatment.
(c) TRPV1þ sensory fibers density in cheek skin at eighth day of AEW treatment. (d) TRPV1þ sensory fibers density is in AEW treated
mice. Data are presented as mean SEM, *p< 0.05, **p< 0.01, ***p< 0.001. Scale bar: 50 mm.
Figure 3. TRPV1þ neuron population is increased in V3 of the Trigeminal ganglion after AEW treatment. PLAP-histochemistry staining of
trigeminal ganglia from AEW-treated TRPV1-PLAP reporter line. (a–d) The proportion of TRPV1þ population is unaffected in V2 of the
Trigeminal ganglion. (e–h) The fraction TRPV1þ neuron in V3 of TG is significantly increased after AEW treatment. Data are presented as
mean SEM, *p< 0.05, **p< 0.01, ***p< 0.001. Scale bar: 100 mm.
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be imaged. However, because the gene expression proﬁle
and physiological properties of sensory neurons likely
are altered by dissociation and in vitro culture, we, sec-
ondly, used a complementary strategy of recording the
calcium activity of sensory neurons in whole TGs from
AEW-treated PirtGCaMP3/þ mice at the fourth day, in
which the calcium indicator GCaMP3 is expressed in
sensory neurons. The proportion of sensory neurons
that responded to 1M capsaicin was signiﬁcantly
increased in the V3 branch of the TG from the
AEW-treated lateral (23.14% 9.71%; normalized by
100mM KCl activation) (Supplemental video. 1) than
those from the contralateral (9.98% 5.80%, p< 0.05)
(Supplemental video. 2). Furthermore, diﬀerence
between the treated and control TGs was observed
upon 10M capsaicin challenge (19.47 10.56 (control)
vs. 38.93 20.07 (AEW fourth day), p< 0.05; Figure 6).
Pain-to-itch switch under chronic itchy conditions
To determine whether this up-regulated TRPV1 expres-
sion underlie the commonly observed ‘‘pain-to-itch’’
switch in chronic itch, we did intradermal injection of
capsaicine into the cheek skin of AEW-treated mice.
Capsaicine usually evokes pain-related wiping behavior,
rather than scratching, in WT mice.14 However, capsai-
cine elicited robust itch-related scratching behavior
(54.00 4.86) on Day 4 of AEW treatment (before the
onset of excessive spontaneous scratching; Figure 7(a)),
compared with water-treated control mice (5.25 1.44,
p< 0.01). Importantly, AEW-treated TRPV1-deﬁcient
mice do not display scratching response to capsaicin
(1.66 0.67), indicating that capsaicin-induced scratching
is mediated by TRPV1 under chronic itch conditions. In
contrast, no diﬀerence was observed between AEW-trea-
ted mice and control WT mice in their pain-related wiping
behavior (48.0 4.08 vs. 37.2 12.12; Figure 7(b)).
As a control, saline injection also elicited a small
increase in scratching in AEW-treated mice
(18.67 7.86), but not in control WT mice (6.00 1.83)
and AEW-treated TRPV1-deﬁcient mice (5.25 1.10). In
contrast, no signiﬁcant diﬀerence was observed in their
wiping behavior (13.00 7.04 vs. 5.25 1.50; Figure 7).
These results suggest that injection-related mechanical
pain also elicits itch under chronic itchy conditions.
Discussion
It has widely observed that hot shower aggrevates itch in
patients living with xerosis (dry skin), atopic dermatitis,
Figure 4. TRPV1 Expression is significantly increased in the trigeminal ganglion after AEW treatment. (a–b) Real-time PCR results
indicate that of the TRPV1 expression is increased after AEW treatment. (c–d) Western blot results confirm an enhanced TRPV1
expression after AEW treatment.
6 Molecular Pain 0(0)
and psoriasis. However, the underlying mechanisms are
unclear. In this study, we combined mouse genetics,
quantitative behavioral assays, sensory ﬁber anatomy,
and GCaMP3-assisted calcium imaging to investigate
the role of heat sensitive channel TPRV1 in chronic
itch and its involvement in mediating pain-to-itch
switch. Our study unravealed an enhanced innervation
density of TRPV1þ sensory ﬁbers in the skin of AEW
model mice, due to an expansion of TRPV1þ sensory
neurons. Moreover, this increased expression of
TRPV1 is essential to neuronal hypersensitivity to cap-
saicine and leads to capsaicine-induced itch under dry
skin conditions. Our ﬁndings thus provide a plausible
mechanism for heat-induced itch in chronic itch and
pave the avenue for future development of eﬀective
novel therapies for itch management.
Our results suggest that sensitization of TRPV1þ
nerve endings underlies pain-to-itch switch (itch
Figure 5. The proportion of TG neurons sensitive to capsaicin is significantly increased in AEW treated mice. (a) Representative images
of GCaMP3 fluorescence in cultured TG neurons from control mice at baseline and after treatment with (b) 50 nM capsaicin and (c) 500 nM
capsaicin. (d) Representative images of GCaMP3 fluorescence in cultured TG neurons from AEW treated mice at baseline and after
treatment with (e) 50 nM capsaicin and (f) 500 nM capsaicin. (g–h) Calcium traces of representative TG neurons from control (g) and AEW
treated mice (h). (i) Compared to control TG neurons, TG neurons from AEW treated mice show significant increases in the fraction
responsive to 50 nM (378 neurons from three mice) and (j) 500 nM capsaicin (656 neurons from three mice). Data are presented as
mean SEM, *p< 0.05, **p< 0.01, ***p< 0.001.
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hypersensitivity). Interestingly, TRPV1-related periph-
eral sensitization is also a well-established mechanism
of chronic pain. NGF has been found to elevate under
inﬂammatory conditions,19 which directly increases the
expression of TRPV1 in sensory neurons. Interestingly,
similar NGF increase was found in the skin and serum of
itchy patients with atopic dermatitis.20 It is, therefore,
reasonable to conceive that the similar mechanism may
mediate the up-regulation of TRPV1 in both chronic itch
and chronic pain.
Figure 6. AEW treatments dramatically increase the sensitivity of sensory neurons to capsaicin in the trigeminal ganglia. (a–d)
Representative images of GCaMP3 fluorescence in whole TG explants from control mice at baseline (a) and after treatment with 1M
capsaicin (b), and 10M capsaicin (c). (d) 100mM KCl was used as the positive control. (e–h) Representative images of GCaMP3 fluor-
escence of TG from mice after three days of AEW treatment at baseline (e) and after treatment with 1M capsaicin (f), 10M capsaicin (g),
and 100mM KCl (h). (j–k) Compared with TGs from control mice (j), there is a significant increase in the fraction of neurons responsive to
capsaicin in TGs from AEW treated mice (k). (i) Percentage of representative neurons from control (j) and AEW treated TGs (k). Data are
presented as mean SEM, *p< 0.05, **p< 0.01, ***p< 0.001.
Figure 7. AEW treated mice show significantly increased scratch behavior after subcutaneous capsaicin injection. (a) Compared with
control mice, AEW treated mice show significantly increased scratching behavior after subcutaneous capsaicin injection (n¼ 5), without
detectable changes in wiping behavior (b). Data are presented as mean SEM, *p< 0.05, **p< 0.01, ***p< 0.001.
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Interestingly, the upregulation of TRPV1 leads to
distinct behavioral consequences (pain vs. itch) in
chronic pain and chronic itch. As NGF indiscriminately
up-regulates the expression of TRPV1 in TrkAþ sensory
neurons, which include both nociceptive neurons and
itch-sensing neurons, the behavioral consequences are
likely due to the central sensitization under diﬀerent con-
ditions. Although capsaicin activates both nociceptive
neurons and itch-sensing neurons via TRPV1, the pain
pathway inhibits the itch pathway under normal and
chronic pain conditions and hence generates pain sensa-
tion. In contrast, in chronic itch, the central sensitization
of itch-signaling pathway could amplify capsaicin-
induced sensory inputs from peripheral itch-sensing neu-
rons, which overpowers the pain pathway and mediates
‘‘pain-to-itch’’ switching in chronic itch. The distinct
behavioral consequences of peripheral sensitization in
chronic itch and chronic pain oﬀer important informa-
tion on the abnormal sensory coding under pathological
conditions and provide new insights on diﬀerence
between chronic itch and chronic pain.
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